Expanded airway portfolio Verathon recently expanded its airway management offerings with GlideScope ClearFit and the BFlex 2.8 single-use bronchoscope, signaling ongoing momentum in high-demand devices that reduce infection risk and streamline workflows. This creates cross-sell opportunities with current customers seeking enhanced visualization, portability, and single-use options in airway and bronchoscopy.

Urology growth The introduction of CFlex, Verathon's first single-use flexible cystoscope, plus updates to the BFlex line, indicates a strategic push in single-use urology solutions. Sales opportunities exist with hospitals and clinics aiming to minimize sterilization turnaround, reduce downtime, and lower total cost of ownership in cystoscopy procedures.

Single-use emphasis Recent launches of single-use devices like CFlex and BFlex 2.8, along with Spectrum QC eco being made from bio-based plastics, show a clear pivot toward disposable technologies. This positions Verathon to target facilities prioritizing infection control, supply chain resilience, and sustainability-driven procurement.

Global footprint Headquartered in the US with international subsidiaries in Canada, Europe, and Asia, Verathon’s global presence supports multi-region sales strategies, channel partnerships, and service agreements. Leverage regional demand for advanced airway, bronchoscopy, and urology solutions to expand enterprise accounts and cross-border contracts.

Financial scale With annual revenue in the 100 to 250 million range and being part of the broader Roper Technologies portfolio, Verathon offers a credible enterprise partner with measurable capacity for large hospital systems, enabling co-marketing, integrated procurement programs, and long-term service commitments.